---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-096305"
form_type: "8-K"
ticker: "VBIO"
cik: "0001787740"
company_name: "Valion Bio, Inc."
filed_at: "2024-08-13T23:59:59+00:00"
generated_at: "2026-05-31T09:46:11.079619+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Tivic Health stockholders approve 10x increase in equity plan shares to 1M

## Summary
- A&R Plan approved, increasing authorized shares from 92,376 to 1,000,000 (over 10x increase).
- Two Class III directors elected: Jennifer Ernst (654,527 for) and Sheryle Bolton (596,810 for).
- Rosenberg Rich Baker Berman ratified as independent auditor for FY2024 with 2,241,997 votes for.
- Annual meeting quorum of approximately 38.7% (2,395,964 of 6,183,592 shares represented).

## SEC filing metadata
- accession: 0000950170-24-096305
- form_type: 8-K
- ticker: VBIO
- cik: 0001787740
- company_name: Valion Bio, Inc.
- filed_at: 2024-08-13T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787740/000095017024096305/0000950170-24-096305-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787740/000095017024096305/tivc-20240809.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-096305
- JSON: https://secwatch.observer/filing/0000950170-24-096305.json
- Plain text: https://secwatch.observer/filing/0000950170-24-096305.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.